leadf
logo-loader
AIM:4BB

4Basebio UK Societas

Receive alerts
Market:
AIM
Market Cap:
£36.95 m
Price
300.00 GBX
Change
-14.29%
52 weeks high
744.00
52 weeks low
175.00

In brief

4basebio UK Societas is developing next-generation gene therapy technologies and solutions.

4basebio started with a focus on the manufacture of synthetic DNA for use in gene therapies; our synthetic DNA has clear safety, efficacy, and cost benefits over current plasmid DNA. Our near-term objective is the development of Good Manufacturing Practice (GMP) grade synthetic DNA as a key milestone in the commercialisation of this core technology.